
USA - NASDAQ:IMGO - US45250K1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 51% to IMGO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-28 | Stifel | Downgrade | Buy -> Hold |
| 2022-11-22 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-11-22 | Jefferies | Downgrade | Buy -> Hold |
| 2022-11-22 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-11-21 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-10-28 | Wedbush | Initiate | Outperform |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-14 | HC Wainwright & Co. | Initiate | Buy |
| 2021-08-10 | Guggenheim | Initiate | Buy |
| 2021-08-10 | Stifel | Initiate | Buy |
| 2021-08-10 | Cowen & Co. | Initiate | Outperform |
| 2021-08-10 | Jefferies | Initiate | Buy |
11 analysts have analysed IMGO and the average price target is 36.72 USD. This implies a price increase of 1.97% is expected in the next year compared to the current price of 36.01.
The consensus rating for IMAGO BIOSCIENCES INC (IMGO) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.